EVALUATION OF KL-6 AND GDF-15 AS NEW SERUM BIOMARKERS FOR RISK STRATIFICATION IN COVID-19 VS. LONGCOVID

Category Primary study
Conference26th IFCC-EFLM EuroMedLab Congress of Clinical Chemistry and Laboratory Medicine and 49th Annual Meeting of the Royal Belgian Society of Laboratory Medicine
Year 2025
This article has no abstract
Epistemonikos ID: 4414f0e3c067e998faff7a794e214bb071db383a
First added on: Sep 16, 2025